Enrolling by invitationNo phase
Immune Cell Gene Study in Triple-Negative Breast Cancer
Studies immune cell receptor genes in people with triple-negative breast cancer.
Plain-language title generated from the registry record
Registry title: Cellular Immune Responses in Triple-negative Breast Cancer - High Throughput Immunogenetic Studies
Key facts
- Where
- Thessaloniki, GreeceSee the site
Where in Greece
- Institute of Applied BiosciencesThessaloniki, GreeceNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Institute of Applied Biosciences
- Trial code
- NCT06646263
- Record updated
- 17 October 2024
- Original description
This project introduces a novel methodology for the in-depth immunogenetic characterization of the TR gene repertoire in solid tumors, holding the promise to offer unprecedented insights into the TR anti-tumor specificity and the prognostic/predictive value of TR gene repertoire signatures.Read full original descriptionShow less
Cellular Immune Responses in Triple-negative Breast Cancer - High Throughput Immunogenetic Studies
This project introduces a novel methodology for the in-depth immunogenetic characterization of the TR gene repertoire in solid tumors, holding the promise to offer unprecedented insights into the TR anti-tumor specificity and the prognostic/predictive value of TR gene repertoire signatures.
Inclusion: Confirmed TNBC diagnosis.
Exclusion: -.